Alpha-synuclein-positive structures induced in leupeptin-infused rats - PubMed (original) (raw)
Comparative Study
Alpha-synuclein-positive structures induced in leupeptin-infused rats
T Nakajima et al. Brain Res. 2005.
Abstract
Abnormal accumulation of alpha-synuclein is regarded as a key pathological step in a wide range of neurodegenerative processes, not only in Parkinson's disease (PD) and dementia with Lewy bodies (DLB) but also in multiple-system atrophy (MSA). Nevertheless, the mechanism of alpha-synuclein accumulation remains unclear. Leupeptin, a protease inhibitor, has been known to cause various neuropathological changes in vivo resembling those of aging or neurodegenerative processes in the human brain, including the accumulation of neuronal processes and neuronal cytoskeletal abnormalities leading to neurofibrillary tangle (NFT)-like formations. In the present study, we administered leupeptin into the rat ventricle and found that alpha-synuclein-positive structures appeared widely in the neuronal tissue, mainly in neuronal processes of the fimbria and alveus. Immunoelectron microscopic study revealed that alpha-synuclein immunoreactivity was located in the swollen axons of the fimbria and alveus, especially in the dilated presynaptic terminals. In addition colocalization of alpha-synuclein with ubiquitin was rarely observed in confocal laser-scan image. This is the first report of experimentally induced in vivo accumulation of alpha-synuclein in non-transgenic rodent brain injected with a well-characterized protease inhibitor by an infusion pump. The present finding suggests that the local accumulation of alpha-synuclein might be induced by the impaired metabolism of alpha-synuclein, which are likely related to lysosomal or ubiquitin-independent proteasomal systems.
Similar articles
- Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein.
Rockenstein E, Schwach G, Ingolic E, Adame A, Crews L, Mante M, Pfragner R, Schreiner E, Windisch M, Masliah E. Rockenstein E, et al. J Neurosci Res. 2005 Apr 15;80(2):247-59. doi: 10.1002/jnr.20446. J Neurosci Res. 2005. PMID: 15765523 - Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses.
Suzuki K, Iseki E, Togo T, Yamaguchi A, Katsuse O, Katsuyama K, Kanzaki S, Shiozaki K, Kawanishi C, Yamashita S, Tanaka Y, Yamanaka S, Hirayasu Y. Suzuki K, et al. Acta Neuropathol. 2007 Nov;114(5):481-9. doi: 10.1007/s00401-007-0264-z. Epub 2007 Jul 25. Acta Neuropathol. 2007. PMID: 17653558 - alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.
Sone M, Yoshida M, Hashizume Y, Hishikawa N, Sobue G. Sone M, et al. Acta Neuropathol. 2005 Jul;110(1):19-26. doi: 10.1007/s00401-005-1013-9. Epub 2005 May 14. Acta Neuropathol. 2005. PMID: 15895299 - The role of alpha-synuclein in neurodegenerative diseases.
Bennett MC. Bennett MC. Pharmacol Ther. 2005 Mar;105(3):311-31. doi: 10.1016/j.pharmthera.2004.10.010. Epub 2004 Dec 8. Pharmacol Ther. 2005. PMID: 15737408 Review. - Clinical overview of the synucleinopathies.
Martí MJ, Tolosa E, Campdelacreu J. Martí MJ, et al. Mov Disord. 2003 Sep;18 Suppl 6:S21-7. doi: 10.1002/mds.10559. Mov Disord. 2003. PMID: 14502652 Review.
Cited by
- Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases.
Spencer B, Potkar R, Trejo M, Rockenstein E, Patrick C, Gindi R, Adame A, Wyss-Coray T, Masliah E. Spencer B, et al. J Neurosci. 2009 Oct 28;29(43):13578-88. doi: 10.1523/JNEUROSCI.4390-09.2009. J Neurosci. 2009. PMID: 19864570 Free PMC article. - Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
Stefanova N, Kaufmann WA, Humpel C, Poewe W, Wenning GK. Stefanova N, et al. Acta Neuropathol. 2012 Jul;124(1):51-65. doi: 10.1007/s00401-012-0977-5. Epub 2012 Apr 11. Acta Neuropathol. 2012. PMID: 22491959 Free PMC article. - Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.
Crews L, Spencer B, Desplats P, Patrick C, Paulino A, Rockenstein E, Hansen L, Adame A, Galasko D, Masliah E. Crews L, et al. PLoS One. 2010 Feb 19;5(2):e9313. doi: 10.1371/journal.pone.0009313. PLoS One. 2010. PMID: 20174468 Free PMC article. Retracted. - Autophagy in dementias.
Kragh CL, Ubhi K, Wyss-Coray T, Masliah E. Kragh CL, et al. Brain Pathol. 2012 Jan;22(1):99-109. doi: 10.1111/j.1750-3639.2011.00545.x. Brain Pathol. 2012. PMID: 22150925 Free PMC article. Review. - Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress.
Höhn A, Tramutola A, Cascella R. Höhn A, et al. Oxid Med Cell Longev. 2020 Mar 27;2020:5497046. doi: 10.1155/2020/5497046. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32308803 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases